Detailed answers about CAPITAL ORTHOPAEDICS & SPORTS MEDICINE LIMITED, including incorporation, status, business activity, and accounts information.
When was CAPITAL ORTHOPAEDICS & SPORTS MEDICINE LIMITED founded?
CAPITAL ORTHOPAEDICS & SPORTS MEDICINE LIMITED was officially incorporated on 22 June 2016 and is registered under company number 10246730. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is CAPITAL ORTHOPAEDICS & SPORTS MEDICINE LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of CAPITAL ORTHOPAEDICS & SPORTS MEDICINE LIMITED?
CAPITAL ORTHOPAEDICS & SPORTS MEDICINE LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does CAPITAL ORTHOPAEDICS & SPORTS MEDICINE LIMITED do?
CAPITAL ORTHOPAEDICS & SPORTS MEDICINE LIMITED operates in the following sector: 86210 - General medical practice activities. This provides insight into the company's primary business activity and industry focus.
What is CAPITAL ORTHOPAEDICS & SPORTS MEDICINE LIMITED's registered address?
The registered office address of CAPITAL ORTHOPAEDICS & SPORTS MEDICINE LIMITED is 238 STATION ROAD, ADDLESTONE, SURREY, ENGLAND, KT15 2PS. This is the official address filed with Companies House for legal and statutory correspondence.
Is CAPITAL ORTHOPAEDICS & SPORTS MEDICINE LIMITED financially stable?
The most recent accounts for CAPITAL ORTHOPAEDICS & SPORTS MEDICINE LIMITED were made up to 30 June 2024, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 March 2026.